182 related articles for article (PubMed ID: 7909561)
1. Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
Long JB; Rigamonti DD; Oleshansky MA; Wingfield CP; Martinez-Arizala A
J Pharmacol Exp Ther; 1994 Apr; 269(1):358-66. PubMed ID: 7909561
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats.
Long JB; Yourick DL; Slusher BS; Robinson MB; Meyerhoff JL
Eur J Pharmacol; 2005 Jan; 508(1-3):115-22. PubMed ID: 15680261
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites.
Hauser KF; Knapp PE; Turbek CS
Exp Neurol; 2001 Mar; 168(1):78-87. PubMed ID: 11170722
[TBL] [Abstract][Full Text] [Related]
4. Arginine8-vasopressin reduces spinal cord blood flow after spinal subarachnoid injection in rats.
Long JB; Martinez-Arizala A; Johnson SH; Holaday JW
J Pharmacol Exp Ther; 1989 May; 249(2):499-506. PubMed ID: 2524587
[TBL] [Abstract][Full Text] [Related]
5. [Effect of neurotoxin on spinal cord injury in rats].
Ye X; Li M; Li J
Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):31-4. PubMed ID: 11715537
[TBL] [Abstract][Full Text] [Related]
6. Topical application of dynorphin A (1-17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury: an experimental study in the rat using electrophysiological and morphological approaches.
Winkler T; Sharma HS; Gordh T; Badgaiyan RD; Stålberg E; Westman J
Amino Acids; 2002; 23(1-3):273-81. PubMed ID: 12373547
[TBL] [Abstract][Full Text] [Related]
7. [Effects of high dose of dynorphin on NMDA receptor and NOS activities in spinal cord of rats].
Qiang W; Sun L; Hu W; Zuo P; Ren M; Liu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):134-8. PubMed ID: 12903514
[TBL] [Abstract][Full Text] [Related]
8. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
[TBL] [Abstract][Full Text] [Related]
9. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.
Hauser KF; Foldes JK; Turbek CS
Exp Neurol; 1999 Dec; 160(2):361-75. PubMed ID: 10619553
[TBL] [Abstract][Full Text] [Related]
10. 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury.
Long JB; Skolnick P
Eur J Pharmacol; 1994 Aug; 261(3):295-301. PubMed ID: 7813551
[TBL] [Abstract][Full Text] [Related]
11. Cobalt accumulation in neurons expressing ionotropic excitatory amino acid receptors in young rat spinal cord: morphology and distribution.
Nagy I; Woolf CJ; Dray A; Urbán L
J Comp Neurol; 1994 Jun; 344(3):321-35. PubMed ID: 8063957
[TBL] [Abstract][Full Text] [Related]
12. Neurologic deficits and neuronal injury in rats resulting from nonopioid actions of the delta opioid receptor antagonist ICI 174864.
Long JB; Petras JM; Holaday JW
J Pharmacol Exp Ther; 1988 Mar; 244(3):1169-77. PubMed ID: 2908046
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal dynorphin A (1-13) and (3-13) reduce spinal cord blood flow by non-opioid mechanisms.
Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
NIDA Res Monogr; 1986; 75():524-6. PubMed ID: 2893280
[TBL] [Abstract][Full Text] [Related]
14. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors.
Wrathall JR; Teng YD; Choiniere D
Exp Neurol; 1996 Jan; 137(1):119-26. PubMed ID: 8566203
[TBL] [Abstract][Full Text] [Related]
16. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
Hao JX; Xu XJ
Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
[TBL] [Abstract][Full Text] [Related]
17. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
Long JB; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
[TBL] [Abstract][Full Text] [Related]
18. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
Wrathall JR; Teng YD; Marriott R
Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
[TBL] [Abstract][Full Text] [Related]
19. Role of aspartate in ischemic spinal cord damage.
Ogata T; Nakamura Y; Tsuji K; Okumura H; Kataoka K; Shibata T
J Orthop Res; 1996 May; 14(3):504-10. PubMed ID: 8676265
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin causes vasoconstriction, reduces blood flow and increases vascular permeability in the rat central nervous system.
Long JB; Rigamonti DD; Dosaka K; Kraimer JM; Martinez-Arizala A
J Pharmacol Exp Ther; 1992 Mar; 260(3):1425-32. PubMed ID: 1347570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
